ユタにおける膠芽腫の臨床試験
ユタ内の拠点で、膠芽腫に関する11件の研究が参加者を募集しています。
ユタ内の都市
公式研究テキスト（英語）
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- University of Utah - Huntsman Cancer Institute, Salt Lake City
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT03970447Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- University of Utah, Hunstman Cancer Institute, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05902169Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Huntsman Cancer Institute, University of Utah, Salt Lake City
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07326566A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT05765812Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Huntsman Cancer Institute/University of Utah, Salt Lake City
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06860594SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Huntsman Cancer Insititute, University of Utah, Salt Lake City
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial
- Huntsman Cancer Institute, Salt Lake City
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT06069726Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- University of Utah, Huntsman Cancer Institute, Salt Lake City
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
- University of Utah, Huntsman Cancer Institute, Salt Lake City
被験者募集中第1相
18歳以上 · 全性別 · 2025/06/25更新 · NCT05879367ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。